Literature DB >> 16188946

Use and significance of anti-CCP autoantibodies in rheumatoid arthritis.

A J W Zendman1, W J van Venrooij, G J M Pruijn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16188946     DOI： 10.1093/rheumatology/kei111

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  42 in total

1.  Anti-cyclic citrullinated peptide antibodies and rheumatoid factor sera titers in leprosy patients from Mexico.

Authors:  María G Zavala-Cerna; Mary Fafutis-Morris; Cecilia Guillen-Vargas; Mario Salazar-Páramo; Diana E García-Cruz; Carlos Riebeling; Arnulfo Nava
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

2.  Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.

Authors:  T C T M van der Pouw Kraan; C A Wijbrandts; L G M van Baarsen; A E Voskuyl; F Rustenburg; J M Baggen; S M Ibrahim; M Fero; B A C Dijkmans; P P Tak; C L Verweij
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

Review 3.  Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.

Authors:  Emilio Martin-Mola; Alejandro Balsa; Rosario García-Vicuna; Juan Gómez-Reino; Miguel Angel González-Gay; Raimon Sanmartí; Estíbaliz Loza
Journal:  Rheumatol Int       Date:  2016-06-06       Impact factor: 2.631

Review 4.  Autoantibody-mediated bone loss.

Authors:  Ulrike Harre; Nicolai A Kittan; Georg Schett
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

Review 5.  MicroRNAs in rheumatoid arthritis.

Authors:  Angela Ceribelli; Md A Nahid; Minoru Satoh; Edward K L Chan
Journal:  FEBS Lett       Date:  2011-05-14       Impact factor: 4.124

6.  A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis.

Authors:  Mittermayer Santiago; Murray Baron; Kiyomitsu Miyachi; Marvin J Fritzler; M Abu-Hakima; S Leclercq; M Bell; M Hudson; J-P Mathieu; S Taillefer; N Jones; P Docherty; M Khraishi; J Markland; J Pope; D Robinson; D Smith; E Sutton
Journal:  Clin Rheumatol       Date:  2007-06-15       Impact factor: 2.980

7.  High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis.

Authors:  Francesca Bobbio-Pallavicini; Roberto Caporali; Claudia Alpini; Stefano Avalle; Oscar M Epis; Catherine Klersy; Carlomaurizio Montecucco
Journal:  Ann Rheum Dis       Date:  2006-11-01       Impact factor: 19.103

8.  Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis.

Authors:  Marja-Kaisa Koivula; Markku Heliövaara; Jarmo Ramberg; Paul Knekt; Harri Rissanen; Timo Palosuo; Juha Risteli
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

9.  Development of proteoglycan-induced arthritis is independent of IL-17.

Authors:  Paul D Doodes; Yanxia Cao; Keith M Hamel; Yumei Wang; Balint Farkas; Yoichiro Iwakura; Alison Finnegan
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Association of anti-CCP positivity with serum ferritin and DAS-28.

Authors:  Burcu Önder; Aydan Kurtaran; Songül Kimyon; Barin Selçuk; Müfit Akyüz
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.